1. Home
  2. IMNM vs VERX Comparison

IMNM vs VERX Comparison

Compare IMNM & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$19.53

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Vertex Inc.

VERX

Vertex Inc.

N/A

Current Price

$12.82

Market Cap

2.3B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNM
VERX
Founded
2006
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
IMNM
VERX
Price
$19.53
$12.82
Analyst Decision
Strong Buy
Buy
Analyst Count
16
15
Target Price
★ $35.20
$17.15
AVG Volume (30 Days)
★ 1.3M
1.2M
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.40
N/A
EPS
N/A
★ N/A
Revenue
$6,941,000.00
★ $748,444,000.00
Revenue This Year
N/A
$10.51
Revenue Next Year
$18,747.97
$10.51
P/E Ratio
★ N/A
$302.25
Revenue Growth
N/A
★ 12.25
52 Week Low
$13.53
$10.21
52 Week High
$30.06
$26.54

Technical Indicators

Market Signals
Indicator
IMNM
VERX
Relative Strength Index (RSI) 30.12 56.37
Support Level $19.39 $12.16
Resistance Level $23.48 $13.56
Average True Range (ATR) 1.12 0.47
MACD -0.27 0.15
Stochastic Oscillator 13.81 91.53

Price Performance

Historical Comparison
IMNM
VERX

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

Share on Social Networks: